Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11860161 Detection and treatment of autoimmune disorders

Patent 11860161 was granted and assigned to Seattle Children's on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Seattle Children's

0

Current Assignee

Seattle Children's

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Anne M. Stevens0

Neelufar Mozaffarian0

Date of Patent

January 2, 2024

0

Patent Application Number

165324350

Date Filed

August 5, 2019

0

Patent Citations

US Patent 8062852 Detection and treatment of autoimmune disorders

0

US Patent 6843990 Monoclonal antibodies for the detection of decoy receptor 3, hybridomas producing said antibodies and uses thereof

0

US Patent 7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis

0

US Patent 7534605 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases

0

US Patent 7588905 Identification and monitoring of systemic lupus erythematosus

0

US Patent 9168296 Detection and treatment of autoimmune disorders

0

Patent Primary Examiner

Ilia I Ouspenski

0

Patent abstract

Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing a PD1 ligand.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11860161 Detection and treatment of autoimmune disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool